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Background.VerylittleisknownaboutolderadultsaccessingHIVcareinsub-SaharanAfrica.MaterialsandMethods.Datawereob-
tained from 18,839 HIV-positive adults at 10 treatment programs in Burundi, Cameroon, and the Democratic Republic of Congo.
We compared characteristics of those aged 50+ with those aged 18–49 using chi-square tests. Logistic regression was used to deter-
mineifagewasassociatedwithmedicationadherence.Results.15%ofadultswere50+years.Thoseaged50+weremoreevenlydis-
tributed between women and men (56% versus 44%) as compared to those aged 18–49 (71% versus 29%) and were more likely to
be hypertensive (8% versus 3%) (P<0.05). Those aged 50+ were more likely to be adherent to their medications than those aged
18–49 (P<0.001). Adults who were not heavy drinkers reported better adherence as compared to those who reported drinking
three or more alcoholic beverages per day (P<0.001). Conclusions. Older adults diﬀered from their younger counterparts in terms
of medication adherence, sociodemographic, behavioral, and clinical characteristics.
1.Introduction
2.8millionpeoplelivingwithHIVworldwideareovertheage
of 50 [1]. In the USA, 24% of all people living with HIV are
older than 50 [2]. In sub-Saharan Africa, more than 14% of
adults with HIV are 50 years or older, and this population is
growing [3]. Perceived risk of contracting HIV among older
adults is low [4] despite physiological changes associated
with aging which place older adults at increased risk of
contracting HIV [5, 6]. HIV disease progresses more rapidly
among older adults than among their younger counterparts,
and mortality among older adults is higher after developing
an AIDS-deﬁning illness [7, 8].
Older adults are more likely to be diagnosed at late stage
of HIV disease progression than their younger counterparts
[8, 9]. This may be due, in part, to low perceived susceptibil-
ity of HIV among older adults [10] as well as their healthcare
providers[11].Oreletal.[12]evaluatedstatedepartmentsof
public health in the USA and concluded that there is a dearth
of HIV/AIDS risk-reduction materials targeting older adults.
A study conducted in eight sub-Saharan African countries
found that older adults had lower levels of knowledge about2 AIDS Research and Treatment
HIV, and, among older adults, women had the lowest levels
of HIV-related knowledge [10]. Few prevention programs in
this setting are aimed at older adults [6].
Interest in HIV and aging is mounting as evidenced by
the increasing body of literature focused on aging, the emer-
gence of meetings such as the 1st International Workshop
on HIV and Aging held in Baltimore, MD, in 2010, and a
growing number of advocacy activities such as the National
HIV/AIDS and Aging Awareness Day, held annually in the
USA since 2009. In turn, focus on behavioral and psychoso-
cial issues associated with HIV and aging is building. Emlet
[13] found that older adults were less likely to disclose their
HIV serostatus to relatives, partners, mental health workers,
neighbors,andchurchmembersthanthoseaged20–39years.
Negin et al. [10] found similar results in sub-Saharan Africa.
One US-based study found that older adults were more
likely than their younger counterparts to be adherent to their
antiretroviral therapy (ART) regimens [14]. In contrast, oth-
ers [15] have found that adherence to ART and other medi-
cations decreases as the number of chronic conditions in-
creases among HIV-positive older adults.
T h o u g hs t r i d e sh a v eb e e nm a d ei nt r e a t m e n ts c a l e - u pi n
sub-Saharan Africa, very little is known about older adults
accessing HIV care and treatment in resource-limited set-
tings. This paper examines whether sociodemographic, be-
havioral, and clinical characteristics of those aged 50+ diﬀer
from those aged 18–49 years. Being over the age of 50 was a
predictor of self-reported adherence according to a previous
analysis of the women in this cohort [16]. The current paper
seeks to extend these ﬁndings by evaluating whether or not
there was an association between age and adherence to ART
orotherHIV-relatedmedicationsintheoverallInternational
Epidemiologic Databases to Evaluate AIDS (IeDEA) Central
Africa region cohort.
2.MaterialsandMethods
The HIV-infected adults included in this analysis were re-
ceiving care at 10 HIV care and treatment facilities contri-
buting data tothe IeDEA Central Africa region database.The
National Institute of Allergy and Infectious Diseases funded
the IeDEA initiative to establish regional centers for the col-
lection and harmonization of HIV-related data. This inter-
national research consortium has enabled researchers in par-
ticipating regions to better describe regional trends as well as
addressuniqueandevolvingresearchquestionsinHIV/AIDS
currently unanswerable by single cohorts. The Central Africa
region database includes data from existing healthcare facili-
ties in the Democratic Republic of the Congo (DRC), where
data collection began in 2007, and Cameroon and Burundi,
where data collection began in 2008. Approval for this re-
search was granted by the Institutional Review Board (IRB)
at the Kinshasa School of Public Health in DRC and RTI
International, as well as the national ethics committees in
Burundi and Cameroon.
SitesprovidingdatatotheIeDEACentralAfricadatabase
wereacombinationofpublicandprivatehospitalandambu-
latory care units of varying size ranging from three patient
beds at one clinic in DRC to 300 beds at the largest hospital
in Cameroon. Participating sites served predominantly ur-
ban populations and oﬀered primary care in DRC and ter-
tiary care in Burundi and Cameroon. All participating sites
recommended and provided routine HIV testing for partici-
pants’ relatives, sex partners, and household members and
had some level of linkage to programs providing prevention
of maternal to child transmission (PMTCT) services. Partic-
ipating sites in Cameroon were the ﬁrst within the IeDEA
Central Africa region to oﬀer free ART for adults in 2000,
while participating sites in DRC started in 2005, followed by
the Burundi site in 2006.
All of the clinic sites contributing data for this analysis
providedindividual adherencecounseling forpatients. Many
sites also oﬀered group counseling on medication adherence.
Frequency of counseling ranged from site to site, with some
programs only providing adherence counseling in the event
of virologic failure, while others provided counseling at ini-
tiation of therapy, and at follow-up clinic visits every one to
three months.
Some sites were also able to provide other types of ART
adherencesupport.ManyofthesitesintheDRCusedfollow-
up appointments to assess adherence, and some distributed
tools such as written or illustrated instructions on when to
take each medication and, to a lesser extent, calendars, alarm
clocks,watches,orpagerstobeusedasreminders.Othersites
used teaching techniques such as quizzes on how and when
to take each medicine as a method of reinforcing the infor-
mation learned in the counseling. At the Cameroon and
Burundi sites, the medical teams also incorporated a phar-
macist into multidisciplinary teams of providers and some
sites had videos with instructions on adherence for patients
to view.
All patient-level adherence data were self-reported and
assessedateachindividual’slastvisitpriortothisanalysis.All
adults, regardless of whether they were on ARVs, were asked
whether they had missed taking their medication more than
two consecutive days in the last month. For those not on
ARVs, missed medications included, most commonly, cot-
rimoxazole prophylaxis and, to a lesser extent, tuberculosis
(TB) prophylaxis and TB treatment. Length of time on ARVs
was calculated by determining the length of time between
the ARV start date and the last follow-up visit prior to this
analysis and was coded as not on ARVs, <6 months, 6–24
months,and>24months.ThoseonARTwerefollowedevery
one to three months and those not on ART were followed
every six months, unless there was a clinical event for which
they needed to return to the clinic for evaluation and/or
care. All patient-level data used in this analysis were collected
during a face-to-face interview with a clinic doctor or nurse.
3.StatisticalAnalysis
AllanalyseswereperformedusingSAS9.1forWindows[17].
We examined baseline sociodemographic, behavioral, and
clinical characteristics of those aged 50+ with those aged 18–
49 years using chi-square tests to determine if distributions
between the two groups diﬀered. We evaluated diﬀerences
between countries using chi-square tests to determine if dis-
tributions between DRC, Cameroon, and Burundi diﬀered.AIDS Research and Treatment 3
We also examined whether age was associated with self-
reportedmedicationadherence.Wedeﬁnednonadherenceas
missed doses (of ART or other HIV-related medications) for
two or more consecutive days in the past 30 days. Logistic
regression was used to determine if age was associated with
medication adherence while controlling for variables such
as country, marital status, gender, employment status, heavy
drinking, education, clinical stage at enrolment into the
IeDEAdatabase,andlengthoftimeonARVs.Includedinthe
model were sociodemographic and clinical characteristics
that we hypothesized a priori might aﬀect adherence based
on reported associations in the literature in the context of
sub-SaharanAfrica[18–20]whilealsoconsideringcomplete-
ness of data in the IeDEA Central Africa database.
4. Results
As of June 2011, there were 18,839 adults enrolled in HIV
care in the IeDEA Central Africa region database and 2,819
(15%) were 50 years old or older (Table 1). The majority
of adults (N = 10,647) were from DRC, 5,835 were from
Cameroon, and 2,357 were from Burundi. Of adults aged
50+, the mean age in both DRC and Cameroon was 55 years
(median 54 years) and 56 years in Burundi (median 55
years).Thoseaged50+weremoreevenlydistributedbetween
women and men (56% versus 44%, resp.) as compared to
thoseaged18–49(71%versus29%,resp.)(P<0.05).Appro-
ximately 20% of both groups reported heavy drinking, deﬁ-
ned as three or more alcoholic drinks per day on average.
Adults were asked about their marital status, whether
theyhadanycasualsexpartnersinthelast6months(deﬁned
as an occasional sex partner in addition to the respondent’s
regular partner), whether they had a sex partner (regular or
casual) that recently died, and whether they used condoms
with their regular partner. One-quarter of those aged 18–49
reported being single, compared to only 5% of older adults
(P<0.05). Seventeen percent of adults 18–49 indicated
they had a casual sex partner within the last 6 months as
compared to 8% of those 50+ (P<0.05). About half (42%)
ofadultsaged50+reportedhavingasexpartnerthatrecently
died as compared to 27% of those aged 18–49 years (P<
0.05). A higher proportion of those aged 18–49 reported
usingcondomswiththeirregularpartner(19%)ascompared
to those aged 50+ (11%) (P<0.05).
We compared HIV serostatus disclosure of those aged
18–49 and 50+ at enrollment into the IeDEA Central Africa
database. A higher proportion of those aged 18–49 as com-
pared to those 50+ had shared their HIV test results with
their partner or spouse (33% versus 27%, resp.) (P<0.05).
The majority had shared their results with a family member
(57% for both groups), while few had shared their results
with a friend (6% versus 4%, resp.), health worker (6% for
both groups), or someone living in the home (2% for both
groups). Few were referred for disclosure counseling at the
baseline visit (3% versus 2%, resp.).
To examine whether older adults were living with fewer
amenities than their younger counterparts, we reviewed
four variables addressing socioeconomic status: education
level, paid profession, access to electricity in the home, and
running water in the home. Older adults were more likely to
report no formal education than their younger counterparts
(14% and 7%, resp.) (P<0.05); however, there were no dif-
ferences between the two age groups for having a paid pro-
fession(42%ofbothgroups),electricity(approximately78%
of both groups) and running water (approximately 61% of
both groups) in the home.
We compared the health status of those aged 18–49 and
50+ at enrollment into the IeDEA Central Africa database.
The majority of both groups entered HIV care through
voluntary counseling and testing (56% and 55%, resp.). The
majority of both groups (64% and 65%, resp.) had mode-
rate-to-severe HIV disease progression classiﬁed as WHO
clinicalstage3or4atenrollmentintotheIeDEAdatabase.Of
the 7,858 adults with CD4 counts available at enrolment
into the IeDEA database, a higher proportion of those aged
18–49 years had CD4 cells counts less than 200 cells/mm3
(44%) as compared to 37% of adults 50+ (P<0.05). A
higher proportion of those aged 50+ (8%) had a history of
hypertension as compared to those aged 18–49 years (3%)
(P<0.05)whilefewhadahistoryofdiabetes(3%versus1%,
resp.). About 20% of both groups had a history of tubercu-
losis.
Recognizing the diversity of the countries included in the
IeDEA Central Africa region, we examined the sociodemo-
graphic, behavioral, and clinical characteristics of the 18,839
HIV+ adults in the database by country (Table 1). A higher
percentageofadultsintheCameroonsites,(35%)weresingle
as compared to adults in the DRC and Burundi sites (17%
for both) (P<0.05). Few adults in the DRC and Cameroon
sites (4% for both) reported having no formal education as
compared to 37% of adults in Burundi (P<0.05). A higher
percentageofadultsintheCameroonsites,reportedhavinga
paid profession (51%), electricity (93%) and running water
(68%) in the home as compared to those in DRC and
Burundi (P<0.05).
Table 2 presents the results of the logistic regression mo-
del used to determine if age was associated with medication
adherence while controlling for variables such as country,
marital status, gender, employment status, heavy drinking,
education, clinical stage at enrolment into the IeDEA data-
base,andlengthoftimeonARVs.Thoseaged50+weremore
likelytobeadherenttotheirmedicationsthanthoseaged18–
49 (P<0.001). Older adults had 1.59 times the odds of being
adherent to their medications as compared to their younger
counterparts. In terms of other predictors of adherence,
adults who were not heavy drinkers had 1.40 times the odds
of being adherent as compared to those who reported drink-
ing three or more alcoholic beverages per day. Those who
were not taking ARVs had 2.05 times the odds of being
adherent to other medications (i.e., cotrimoxazole prophy-
laxis) as compared to those on ARVs for less than 6 months.
Adults from the Burundi site had 2.23 times the odds of
being adherent to their medications as compared to those
from the DRC sites (P<0.001). Adults from the Cameroon
sites had 1.98 times the odds of being adherent to their
medications as compared to those from the DRC sites (P<
0.001).4 AIDS Research and Treatment
Table 1: Characteristics of 18,839a HIV+ adults in IeDEA Central Africa database presented by age (18–49 years, 50+ years) and by country
(DRC, Cameroon, Burundi).
Characteristic 18–49 years N (%) 50+ years N (%) DRC N (%) Cameroon N (%) Burundi N (%)
Sex∗ 15,979 2,812 10,605 5,834 2,352
Male 4,573 (28.6) 1,243 (44.2) 3,348 (31.6) 1,749 (30.0) 719 (30.6)
Female 11,406 (71.4) 1,569 (55.8) 7,257 (68.4) 4,085 (70.0) 1,633 (69.4)
Marital status∗∧ 15,662 2,781 10,252 5,835 2,356
Single 4,002 (25.6) 138 (5.0) 1,694 (16.5) 2,053 (35.2) 393 (16.7)
Divorced 1,345 (8.6) 311 (11.2) 1,110 (10.8) 316 (5.4) 230 (9.8)
Widowed 2,807 (17.9) 1,120 (40.3) 2,469 (24.1) 916 (15.7) 542 (23.0)
Living together-not married 1,622 (10.4) 74 (2.7) 732 (7.1) 624 (10.7) 340 (14.4)
Monogamous marriage 5,407 (34.5) 1,009 (36.3) 3,841 (37.5) 1,751 (30.0) 824 (35.0)
Polygamous marriage 479 (3.1) 129 (4.6) 406 (4.0) 175 (3.0) 27 (1.1)
Education∗∧ 15,999 2,808 10,616 5,835 2,356
None 1,110 (6.9) 385 (13.7) 371 (3.5) 253 (4.3) 871 (37.0)
Primary school 6,915 (43.2) 959 (34.2) 4,450 (41.9) 3,006 (51.5) 418 (17.7)
Secondary school 6,260 (39.1) 1,134 (40.4) 4,447 (41.9) 1,935 (33.2) 1,012 (43.0)
University 1,714 (10.7) 330 (11.8) 1,348 (12.7) 641 (11.0) 55 (2.3)
Socioeconomic indicators
Paid profession∧ 6,727 (42.1) 1,187 (42.2) 4,127 (38.9) 2,984 (51.1) 803 (34.1)
Electricity in the home∧ 12,623 (78.9) 2,204 (78.3) 8,419 (79.3) 5,417 (92.8) 991 (42.1)
Running water in the home∧ 9,686 (60.5) 1,733 (61.6) 6,568 (61.8) 3,967 (68.0) 884 (37.5)
E n t r yi n t oH I Vc a r e ∗∧ 15,918 2,796 10,522 5,835 2,357
PMTCT 381 (2.4) 7 (0.3) 69 (0.7) 246 (4.2) 73 (3.1)
TB clinic 495 (3.1) 65 (2.3) 262 (2.5) 277 (4.7) 21 (0.9)
STI clinic 330 (2.1) 75 (2.7) 59 (0.6) 341 (5.8) 5 (0.2)
VCT 8,902 (55.9) 1,523 (54.5) 6,164 (58.6) 2,343 (40.2) 1,918 (81.4)
No previous care 4,032 (25.3) 778 (27.8) 3,292 (31.3) 1,447 (24.8) 71 (3.0)
Other 1,778 (11.2) 348 (12.4) 676 (6.4) 1,181 (20.2) 269 (11.4)
Clinical stage (WHO) at enrollment into
IeDEA database∗∧ 15,900 2,800 10,530 5,819 2,351
1 2,387 (15.0) 303 (10.8) 989 (9.4) 915 (15.7) 787 (33.5)
2 3,348 (21.1) 658 (23.5) 2,469 (23.4) 1,136 (19.5) 401 (17.1)
3 8,603 (54.1) 1,588 (56.7) 6,443 (61.2) 2,911 (50.0) 836 (35.6)
4 1,562 (9.8) 251 (9.0) 629 (6.0) 857 (14.7) 327 (13.9)
CD4 count at enrollment into IeDEA
database∗∧ 6,737 1,121 1,723 4,862 1,273
<200 2,982 (44.3) 413 (36.8) 706 (41.0) 2,310 (47.5) 379 (29.8)
200–350 1,921 (28.5) 353 (31.5) 502 (29.1) 1,405 (28.9) 367 (28.8)
>350 1,834 (27.2) 355 (31.7) 515 (29.9) 1,147 (23.6) 527 (41.4)
Length of time on ARVs∗∧ 8,912 1,644 5,525 3,737 1,304
<6 months 1,467 (16.5) 239 (14.5) 1,324 (24.0) 297 (7.9) 85 (6.5)
6–24 months 2,404 (27.0) 388 (23.6) 1,436 (26.0) 1,007 (26.9) 346 (26.5)
>24 months 5,041 (56.6) 1,017 (61.9) 2,765 (50.0) 2,433 (65.1) 873 (66.9)
Comorbidity history
History of TB∧ 3,237 (20.2) 538 (19.1) 2,553 (24.1) 669 (11.5) 553 (23.5)
History of diabetes∗∧ 213 (1.3) 71 (2.5) 194 (1.8) 68 (1.2) 22 (0.9)
History of high blood pressure∗∧ 501 (3.1) 234 (8.3) 492 (4.6) 163 (2.8) 80 (3.4)AIDS Research and Treatment 5
Table 1: Continued.
Characteristic 18–49 years N (%) 50+ years N (%) DRC N (%) Cameroon N (%) Burundi N (%)
Has had a casual sex partner in last 6
months∗∧ 2,673 (16.7) 232 (8.2) 1,082 (10.2) 1,569 (26.9) 254 (10.8)
Sex partner (regular or casual) who has
recently died∗∧ 4,360 (27.2) 1,188 (42.1) 2,703 (25.4) 1,955 (33.5) 890 (37.8)
Condom use with regular partner∗∧ 2,968 (18.5) 311 (11.0) 985 (9.3) 1,648 (28.2) 646 (27.4)
Heavy drinking (on average 3+
drinks/day)∗∧ 3,369 (21.1) 636 (22.7) 2,207 (20.9) 1,389 (23.8) 409 (17.4)
HIV test result disclosure
Partner/spouse∗∧ 5,255 (32.8) 771 (27.4) 2,755 (25.9) 2,093 (35.9) 1,178 (50.0)
Friend∗∧ 908 (5.7) 113 (4.0) 277 (2.6) 406 (7.0) 338 (14.3)
Family member∧ 9,116 (56.9) 1,618 (57.4) 5,693 (53.5) 3,959 (67.8) 1,082 (45.9)
Health worker∧ 881 (5.5) 169 (6.0) 254 (2.4) 776 (13.3) 20 (0.8)
Someone living in the home∧ 311 (1.9) 68 (2.4) 308 (2.9) 39 (0.7) 32 (1.4)
Referral made for disclosure counseling 528 (3.3) 61 (2.2) 115 (1.1) 471 (8.1) 3 (0.1)
aVariables do not add to total number of adults in the database (18,839) due to missing data.
∗Signiﬁcant diﬀerences found between adults 18–49 years and adults 50+ years distributions (α = 0.05).
∧Signiﬁcant diﬀerences found between DRC, Cameroon, and Burundi distributions (α = 0.05).
5. Discussion
Fifteen percent of this large cohort of HIV-infected adults
were 50 years old or older. Though older adults were more
likely to report no formal education than their younger
counterparts, they did not seem to be living with fewer
amenities as per the socioeconomic variables examined in
this study: having a paid profession, access to electricity, and
running water in the home. We found that older adults were
more likely to be adherent to their medications than
their younger counterparts. In terms of other predictors of
adherence,wefoundthatadultswhowerenotheavydrinkers
reported better adherence as compared to those who repor-
ted drinking three or more alcoholic beverages per day.
Older adults have been found to be more adherent to
HIV medications, including ART, than their younger coun-
terparts, which may improve their survival and response to
treatment [14]. Though we found adults aged 50+ years to
be more adherent to their medications than those aged 18–
49, further inquiry is needed to determine if the older adults
in this cohort, in turn, experience an improved response to
ART and survival.
Alcohol abuse has been found to negatively aﬀect adher-
ence in sub-Saharan Africa (see Mills et al. [19]f o rar e v i e w )
andourresultsprovidefurthersupport.Wefoundthatadults
who were not heavy drinkers reported better adherence as
compared to those who reported drinking three or more
alcoholic beverages per day. A similar proportion of older
and younger adults reported heavy drinking (23% and 21%,
resp.). However, it is important to note that those aged 50+
were more evenly distributed between women and men as
compared to those aged 18–49, and, in this cohort, men
tended to report alcohol use more frequently than women.
Our results suggest that those reporting heavy alcohol use
may beneﬁt from additional adherence counseling. Those
whowerenottakingARVsreportedbetteradherencetoother
medications(i.e.,cotrimoxazoleprophylaxis)ascomparedto
those on ARVs for less than 6 months, supporting the notion
that additional adherence counseling for new ART users may
be beneﬁcial.
Older adults in sub-Saharan Africa have been found to
be less likely to discuss HIV prevention with their partner
as compared to their younger counterparts [10]. The results
of the current study echo these ﬁndings. Disclosure of HIV
test results with partners/spouse as well as condom use with
regular partner was higher among those aged 18–49 as com-
pared to those aged 50+. Further, HIV programming in sub-
Saharan Africa is generally targeted towards younger adults,
not those over 50 [3, 21]. Older adults as compared to their
younger counterparts have been found to be less likely to
have been tested for HIV [10] and experience delays in diag-
nosis and treatment [8, 9], as clinicians may not routinely
screen older adults for HIV or recognize their signs and sym-
ptoms as those of HIV [11]. In the current study, the majo-
rity of both age groups had moderate-to-severe HIV disease
progression classiﬁed as WHO clinical stage 3 or 4 at enroll-
ment into the IeDEA database, which corresponded to entry
into HIV care for many adults.
OlderadultsareatincreasedriskforHIVinfectiondueto
biological and social factors [5, 6]. For women, in particular,
age is associated with thinning of vaginal membranes and
reducedvaginallubrication,whichcanleadtotearingduring
sexual intercourse [5]. Social factors may place older adults
at risk for HIV, such as divorce or death of a spouse, which
may lead to new sexual partners and thus risk of exposure
[5]. In sub-Saharan Africa, cultural practices, such as wife
inheritance,mayalsoplacewomenatriskofcontractingHIV
in the event of the death of a spouse [6]. In the current study,
a greater proportion of older adults as compared to those
aged 18–49 were widowed (40% versus 18%, resp.) or divor-
ced (11% versus 9%, resp.).6 AIDS Research and Treatment
Table 2: Adjusted1 odds ratios and 95% conﬁdence intervals for the association of medication adherence2 and age.
Variable Medication adherence
Odds ratio 95% conﬁdence interval P value
Main eﬀect variable
Age
18–49 years Ref <0.001
50+ years 1.59∗ (1.21, 2.09)
Covariates
Country
DRC Ref <0.001
Burundi 2.23∗ (1.57, 3.15)
Cameroon 1.98∗ (1.60, 2.46)
Marital status
Single Ref 0.848
Divorced 1.05 (0.76, 1.46)
Widowed 1.11 (0.85, 1.44)
Married/living together
(includes monogamous and
polygamous marriage)
1.09 (0.88, 1.36)
Sex
Female Ref 0.569
Male 0.95 (0.78, 1.15)
Employment status
No paid employment Ref 0.813
Paid employment 1.02 (0.86, 1.22)
Heavy drinking
Yes Ref <0.001
No 1.40∗ (1.15, 1.70)
Education level
Secondary/University Ref 0.216
Primary 0.94 (0.79, 1.12)
No formal education 0.72 (0.50, 1.05)
Clinical stage (WHO) at enrollment into
IeDEA database
I/II Ref 0.774
III/IV 0.97 (0.82, 1.17)
Length of time on ARVs
<6m o n t h s Ref <0.001
6–24 months 0.69∗ (0.53, 0.89)
>24 months 1.12 (0.87, 1.45)
Not on ARVs 2.05∗ (1.51, 2.78)
∗P<0.001.
1Adjusted for country, marital status, gender, employment status, heavy drinking, education, clinical stage at enrollment into IeDEA database, and length of
time on ARVs.
2Nonadherence was deﬁned as missed doses of ART or other HIV-related medications (most commonly cotrimoxazole prophylaxis and, to a lesser extent, TB
prophylaxis and TB treatment) for two or more consecutive days in the past 30 days.
6. Limitations
Ourresultsshouldbeconsideredinlightofseveralstudylim-
itations. The adherence data for this study were self-reported
and collected during face-to-face interviews with a clinic
doctorornurse,whichcanleadtosocialdesirabilitybiasand,
in turn, inﬂated adherence estimations [22]. Our baseline
data were derived at enrollment into the IeDEA Central
Africa database. For many adults, this also corresponded to
enrollmentintoHIVcare.ThoughwewereabletodetermineAIDS Research and Treatment 7
when ART was started, we were not able to assess how long
the patient had been in HIV care before enrolling into the
IeDEA database.
The data presented in this paper provide a snapshot of
patient characteristics from a broad range of private and
public hospitals and ambulatory care units of varying size
and capacity. However, the data are not nationally represen-
tative as they were not derived from randomly selected HIV
care facilities. Though describing regional trends was an
objective of the larger study, exploring diﬀerences between
age groups was not an original goal. Collecting additional
data on psychosocial variables, such as social support, dep-
ression, stigma, and quality of life, would have been insight-
ful for examining potential diﬀerences between older adults
and their younger counterparts.
7. Conclusions
This is the ﬁrst study to examine whether there are diﬀer-
ences between older adults and their younger counterparts
accessing HIV care and treatment in the central Africa re-
gion. These results are noteworthy as they provide insight
into the sociodemographic, behavioral, and clinical charac-
teristics of HIV-infected older adults in this region. Though
wefoundolderadultsweremorelikelytobeadherenttotheir
medications than their younger counterparts, further in-
quiry is needed to better understand factors aﬀecting ART
adherence, response to treatment, and survival of older
adults receiving HIV care in sub-Saharan Africa. We found
that heaving drinking negatively aﬀected medication adher-
ence, which suggests that those reporting heavy alcohol use
may beneﬁt from additional adherence counseling.
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